CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$1.01
-0.02 (-1.94%)
Open$1.00
Previous Close$1.03
Day High$1.04
Day Low$0.98
52W High$6.25
52W Low$0.62
Volume—
Avg Volume2.35M
Market Cap6.79M
P/E Ratio—
EPS$-1.97
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,205.9% upside
Current
$1.01
$1.01
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.1K | 42.3K | 749.0K |
| Net Income | -17,257,048 | -38,301,709 | -154,552 |
| Profit Margin | -99,916.8% | -94,921.0% | -20.6% |
| EBITDA | -17,327,009 | -40,593,485 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -59.5% | -59.5% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |